AL amyloidosis and progression to multiple myeloma with gain(1q)

被引：8

作者：

Hoffman, James ^{[1
]}

Jhanwar, Suresh ^{[1
]}

Comenzo, Raymond L. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2009年 / 144卷 / 06期

关键词：

amyloidosis; cytogenetics; multiple myeloma; LIGHT-CHAIN AMYLOIDOSIS; INSTABILITY; TRIAL;

D O I：

10.1111/j.1365-2141.2008.07536.x

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：963 / 964

页数：2

共 11 条

[1]

Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2 [J].

Arendt, Bonnie K. ;

Ramirez-Alvarado, Marina ;

Sikkink, Laura A. ;

Keats, Jonathan J. ;

Ahmann, Gregory J. ;

Dispenzieri, Angela ;

Fonseca, Rafael ;

Ketterling, Rhett P. ;

Knudson, Ryan A. ;

Mulvihill, Erin M. ;

Tschurnper, Renee C. ;

Wu, Xiaosheng ;

Zeldenrust, Steven R. ;

Jelinek, Diane F. .

BLOOD, 2008, 112 (05) :1931-1941

[2]

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability [J].

Bochtler, Tilmann ;

Hegenbart, Ute ;

Cremer, Friedrich W. ;

Heiss, Christiane ;

Benner, Axel ;

Hose, Dirk ;

Moos, Marion ;

Bila, Jelena ;

Bartram, Claus R. ;

Ho, Anthony D. ;

Goldschmidt, Hartmut ;

Jauch, Anna ;

Schonland, Stefan O. .

BLOOD, 2008, 111 (09) :4700-4705

[3]

Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis:: results of a phase II trial [J].

Cohen, Adam D. ;

Zhou, Ping ;

Chou, Joanne ;

Teruya-Feldstein, Julie ;

Reich, Lilian ;

Hassoun, Hani ;

Levine, Beth ;

Filippa, Daniel A. ;

Riedel, Elyn ;

Kewalramani, Tarun ;

Stubblefield, Michael D. ;

Fleisher, Martin ;

Nimer, Stephen ;

Comenzo, Raymond L. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (02) :224-233

[4]

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis [J].

Gertz, MA ;

Comenzo, R ;

Falk, RH ;

Fermand, JP ;

Hazenberg, BP ;

Hawkins, PN ;

Merlini, G ;

Moreau, P ;

Ronco, P ;

Sanchorawala, V ;

Sezer, O ;

Solomon, A ;

Grateau, G .

AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (04) :319-328

[5]

A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine [J].

Kyle, RA ;

Gertz, MA ;

Greipp, PR ;

Witzig, TE ;

Lust, JA ;

Lacy, MQ ;

Therneau, TM .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (17) :1202-1207

[6]

Kyle RA, 2003, BRIT J HAEMATOL, V121, P749

[7]

Dangerous small B-cell clones [J].

Merlini, Giampaolo ;

Stone, Marvin J. .

BLOOD, 2006, 108 (08) :2520-2530

[8]

Rajkumar SV, 1998, CANCER-AM CANCER SOC, V82, P1501, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO

[9]

2-8

[10]

Genomic instability in multiple myeloma: Evidence for jumping segmental duplications of chromosome arm Iq [J].

Sawyer, JR ;

Tricot, G ;

Lukacs, JL ;

Binz, RL ;

Tian, E ;

Barlogie, B ;

Shaughnessy, J .

GENES CHROMOSOMES & CANCER, 2005, 42 (01) :95-106

← 1 2 →